Laura E. Benjamin

13.9k total citations · 4 hit papers
70 papers, 10.8k citations indexed

About

Laura E. Benjamin is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Laura E. Benjamin has authored 70 papers receiving a total of 10.8k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Molecular Biology, 18 papers in Cancer Research and 16 papers in Oncology. Recurrent topics in Laura E. Benjamin's work include Angiogenesis and VEGF in Cancer (34 papers), Cancer, Hypoxia, and Metabolism (16 papers) and PI3K/AKT/mTOR signaling in cancer (9 papers). Laura E. Benjamin is often cited by papers focused on Angiogenesis and VEGF in Cancer (34 papers), Cancer, Hypoxia, and Metabolism (16 papers) and PI3K/AKT/mTOR signaling in cancer (9 papers). Laura E. Benjamin collaborates with scholars based in United States, Israel and South Korea. Laura E. Benjamin's co-authors include Gabriele Bergers, Eli Keshet, Itzhak Hemo, Dragan Golijanin, Ahuva Itin, Dov Pode, Janice A. Nagy, Harold F. Dvorak, Ann M. Dvořàk and Huiyan Zeng and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Laura E. Benjamin

70 papers receiving 10.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tumorigenesis and the angiogenic switch

2003 2.7k citations Laura E. Benjamin et al. profile →
A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF

1998 989 citations Laura E. Benjamin et al. profile →
Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal

1999 975 citations Laura E. Benjamin et al. profile →
Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis

2010 955 citations Yingdi Wang, Masanori Nakayama et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Laura E. Benjamin United States	38	6.9k	2.8k	2.6k	1.2k	1.1k	70	10.8k
Jocelyn Holash United States	34	8.1k 1.2×	3.0k 1.1×	2.7k 1.0×	1.1k 0.9×	1.0k 1.0×	46	11.9k
Rolf Bjerkvig Norway	59	6.3k 0.9×	3.3k 1.2×	3.4k 1.3×	956 0.8×	1.5k 1.4×	235	12.7k
Evelyn Flynn United States	36	6.8k 1.0×	3.1k 1.1×	2.5k 1.0×	1.1k 1.0×	886 0.8×	66	11.4k
Paul N. Span Netherlands	57	5.1k 0.7×	3.1k 1.1×	2.5k 1.0×	1.3k 1.1×	984 0.9×	233	9.7k
Kevin P. Claffey United States	52	7.6k 1.1×	2.5k 0.9×	3.0k 1.1×	768 0.6×	1.2k 1.1×	98	11.7k
Olga V. Volpert United States	57	8.4k 1.2×	4.0k 1.4×	2.3k 0.9×	878 0.7×	1.1k 1.0×	107	12.5k
Kristian Pietras Sweden	46	6.4k 0.9×	2.6k 1.0×	4.3k 1.7×	1.8k 1.5×	1.1k 1.0×	99	12.2k
William P. Schiemann United States	59	6.8k 1.0×	2.4k 0.9×	3.5k 1.4×	1.3k 1.1×	924 0.9×	132	11.1k
Alfredo Molinolo United States	60	5.0k 0.7×	1.7k 0.6×	3.8k 1.5×	1.3k 1.1×	892 0.8×	171	10.2k
J Folkman United States	21	6.2k 0.9×	3.0k 1.1×	2.6k 1.0×	1.2k 1.0×	816 0.8×	30	10.3k

Countries citing papers authored by Laura E. Benjamin

Since Specialization

Citations

This map shows the geographic impact of Laura E. Benjamin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura E. Benjamin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura E. Benjamin more than expected).

Fields of papers citing papers by Laura E. Benjamin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura E. Benjamin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura E. Benjamin. The network helps show where Laura E. Benjamin may publish in the future.

Co-authorship network of co-authors of Laura E. Benjamin

This figure shows the co-authorship network connecting the top 25 collaborators of Laura E. Benjamin. A scholar is included among the top collaborators of Laura E. Benjamin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura E. Benjamin. Laura E. Benjamin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fu, Siqing, Bradley R. Corr, Kerry Culm-Merdek, et al.. (2022). Phase Ib Study of Navicixizumab Plus Paclitaxel in Patients With Platinum-Resistant Ovarian, Primary Peritoneal, or Fallopian Tube Cancer. Journal of Clinical Oncology. 40(23). 2568–2577. 36 indexed citations

Fischl, Anthony S., Xiaoen Wang, Beverly L. Falcón, et al.. (2019). Inhibition of Sphingosine Phosphate Receptor 1 Signaling Enhances the Efficacy of VEGF Receptor Inhibition. Molecular Cancer Therapeutics. 18(4). 856–867. 16 indexed citations

Cohen, Yoni, Hagit Dafni, Reut Avni, et al.. (2015). Genetic and Pharmacological Modulation of Akt1 for Improving Ovarian Graft Revascularization in a Mouse Model1. Biology of Reproduction. 94(1). 14–14. 9 indexed citations

Phung, Thuy L., Wa Du, Qi Xue, et al.. (2014). Akt1 and Akt3 Exert Opposing Roles in the Regulation of Vascular Tumor Growth. Cancer Research. 75(1). 40–50. 40 indexed citations

Liu, Yuhong, Jun Feng, Mohammed Arafah, et al.. (2013). Oxidative stress improves coronary endothelial function through activation of the pro-survival kinase AMPK. Aging. 5(7). 515–530. 65 indexed citations

Kazerounian, Shiva, Damien Gerald, Minzhou Huang, et al.. (2012). RhoB Differentially Controls Akt Function in Tumor Cells and Stromal Endothelial Cells during Breast Tumorigenesis. Cancer Research. 73(1). 50–61. 40 indexed citations

Sawada, Naoki, Kevin Croce, Yevgenia Tesmenitsky, et al.. (2012). Abstract 19681: Endothelial PGC-1alpha Mediates Vascular Dysfunction in Diabetes. Circulation. 126(suppl_21). 1 indexed citations

Holopainen, Tanja, Pipsa Saharinen, Gabriela D’Amico, et al.. (2012). Effects of Angiopoietin-2-Blocking Antibody on Endothelial Cell–Cell Junctions and Lung Metastasis. JNCI Journal of the National Cancer Institute. 104(6). 461–475. 6 indexed citations

Bravo‐Nuevo, Arturo, Rebekah K. O’Donnell, Alexander Rosendahl, et al.. (2011). RhoB deficiency in thymic medullary epithelium leads to early thymic atrophy. International Immunology. 23(10). 593–600. 20 indexed citations

10.

Nucera, Carmelo, Alessandro Porrello, Zeus A. Antonello, et al.. (2010). B-Raf ^V600E and thrombospondin-1 promote thyroid cancer progression. Proceedings of the National Academy of Sciences. 107(23). 10649–10654. 149 indexed citations

11.

Wang, Yingdi, Masanori Nakayama, Mara E. Pitulescu, et al.. (2010). Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis. Nature. 465(7297). 483–486. 955 indexed citations breakdown →

12.

Hiroi, Yukio, Naoki Sawada, Salvatore Salomone, et al.. (2009). Obesity Increases Vascular Senescence and Susceptibility to Ischemic Injury Through Chronic Activation of Akt and mTOR. Science Signaling. 2(62). ra11–ra11. 133 indexed citations

13.

Xue, Qi, Benjamin D. Hopkins, Carole Perruzzi, et al.. (2008). Palomid 529, a Novel Small-Molecule Drug, Is a TORC1/TORC2 Inhibitor That Reduces Tumor Growth, Tumor Angiogenesis, and Vascular Permeability. Cancer Research. 68(22). 9551–9557. 87 indexed citations

14.

Phung, Thuy L., Carole Perruzzi, Rita A. Monahan-Earley, et al.. (2006). Pathological angiogenesis is induced by sustained Akt signaling and inhibited by rapamycin.. Cancer Research. 66. 1342–1342. 6 indexed citations

15.

Phung, Thuy L., Keren Ziv, Donnette Dabydeen, et al.. (2006). Pathological angiogenesis is induced by sustained Akt signaling and inhibited by rapamycin. Cancer Cell. 10(2). 159–170. 356 indexed citations

16.

Sund, Malin, Yuki Hamano, Hikaru Sugimoto, et al.. (2005). Function of endogenous inhibitors of angiogenesis as endothelium-specific tumor suppressors. Proceedings of the National Academy of Sciences. 102(8). 2934–2939. 130 indexed citations

17.

Nagy, Janice A., Eliza Vasile, Dian Feng, et al.. (2002). Vascular Permeability Factor/Vascular Endothelial Growth Factor Induces Lymphangiogenesis as well as Angiogenesis. The Journal of Experimental Medicine. 196(11). 1497–1506. 436 indexed citations

18.

Benjamin, Laura E.. (2001). Glucose, VEGF-A, and Diabetic Complications. American Journal Of Pathology. 158(4). 1181–1184. 55 indexed citations

19.

Abramovitch, Rinat, et al.. (1999). In vivo prediction of vascular susceptibility to vascular susceptibility endothelial growth factor withdrawal: magnetic resonance imaging of C6 rat glioma in nude mice.. PubMed. 59(19). 5012–6. 107 indexed citations

20.

Benjamin, Laura E., William J. Fredericks, Frederic G. Barr, & Frank J. Rauscher. (1996). Fusion of theEWS1 andWT1 genes as a result of the t(11;22)(p13;q12) translocation in desmoplastic small round cell tumors. Medical and Pediatric Oncology. 27(5). 434–439. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact